| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 264ARM7UXX |
| InChI Key | PRXXYMVLYKJITB-IZZDOVSWSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H21N5O3S |
| Molecular Weight | 447.52 |
| AlogP | 3.36 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 112.01 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 32.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 1200-1200 | - | - | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
- | 9700 | - | - | - | |
|
Epigenetic regulator
Eraser
Lysine demethylase
Lysine-specific demethylase
|
- | 600 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Carcinoma, Merkel Cell | 2 | D015266 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 910462-43-0 |
| ChEMBL | CHEMBL4283683 |
| DrugBank | DB13101 |
| FDA SRS | 264ARM7UXX |
| PubChem | 15985904 |
| SureChEMBL | SCHEMBL1613939 |
| ZINC | ZINC000034851244 |